MoNo chem-pharm Produkte

What MoNo chem-pharm Produkte does

MoNo chem-pharm Produkte GmbH is an Austrian pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Vienna, specializing in sterile and non-sterile liquid pharmaceutical products. The company was established in 2000 as a spin-off from Sigmapharm, which had been founded in 1949, and inherits more than seven decades of formulation and manufacturing know-how. It operates two production facilities: the original Vienna site on Leystraße and a second site in Hornstein that opened in 2019. The workforce is in the 51–100 employee band.

The company's product portfolio is centered on liquid dosage forms including nasal sprays, throat sprays, eye drops, and vials, with a combined production capacity of approximately 12 million packs per year. It holds multiple regulatory certifications relevant to pharmaceutical and medical-device manufacturing — EU-GMP, EN ISO 13485, EU-MDR, and MDD — which qualify its output for the European market. The business model is B2B contract manufacturing on behalf of pharmaceutical, medical-device, food-supplement, and CRO customers, with quote-based project pricing rather than disclosed subscription or platform economics. MoNo operates as a private company with no public funding rounds, M&A activity, or external investors in the available record.

Name

MoNo chem-pharm Produkte

Legal name

MoNo chem-pharm Produkte GmbH

Website

https://mono.co.at

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

Austrian pharmaceutical CDMO founded in 2000 as a Sigmapharm spin-off, operating production sites in Vienna and Hornstein. Contract manufactures sterile and non-sterile liquid pharmaceuticals — nasal sprays, eye drops, vials — for pharma, medical-device, and supplement clients.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAFALAE

Compounding Pharmacies (Sterile/Non-Sterile)

Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

SECONDARYHLAGACAK

Clinical Trial Pharmacy & IMP Management at Site

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYIMALAIAJ

Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features)

Industrials, Manufacturing & Construction/Packaging & Containers/Pharmaceutical & Medical Packaging

Keywords

• Pharmaceutical contract manufacturing
• Sterile liquid manufacturing
• Aseptic fill finish
• GMP manufacturing services
• Pharmaceutical development services

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D

Revenue model

1. Contract Manufacturing Services: Lohnfertigung (contract manufacturing) services for pharmaceutical liquids including sterile and non-sterile products. Revenue generated through manufacturing fees based on batch sizes, production complexity, and regulatory requirements. Services span from product development through production to packaging and serialization.
2. Product Development Services: Comprehensive product development services from concept to market launch, including formulation development, process optimization, method development, and regulatory submission documentation support.
3. Quality Control and Release Services: Analytical testing services including raw material testing, in-process controls, finished product analysis, stability testing, and batch release services by qualified persons.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

MoNo chem-pharm Produkte GmbH is an Austrian pharmaceutical contract manufacturer that develops and produces sterile and non-sterile liquid pharmaceuticals (nasal sprays, throat sprays, eye drops, vials) for pharmaceutical, medical device, food supplement, and clinical trial sponsors. Services span aseptic manufacturing, product development, quality control with advanced analytics, serialization for EU Falsified Medicines Directive compliance, and repackaging, delivered from EU-GMP and ISO 13485 certified facilities in Vienna and Hornstein.

Product overview

MoNo chem-pharm Produkte GmbH is an Austrian pharmaceutical contract manufacturer offering a comprehensive portfolio of pharmaceutical manufacturing services. The core offerings include Sterile Solutions (aseptic manufacturing of nasal sprays, throat sprays, eye drops, and vials) and Non-Sterile Solutions (production of liquid pharmaceuticals, medical devices, and food supplements). These are supported by add-on services including Small Batch Service, Study Medication/Clinical Trial Service, Serialisation, Repackaging, Product Development, and Quality Control. The company operates two production sites in Vienna and Hornstein, certified to EU-GMP, EN ISO 13485, and EU-MDR standards, with capacity of approximately 12 million packs per year.

Differentiator

Problem solved

Functional benefit

Products and services

• Sterile Solutions (Sterile Lösungen) Aseptic manufacturing and filling of sterile liquid pharmaceutical products including nasal sprays, throat sprays, eye drops, and vials in aqueous, oily, alcoholic, and viscous formulations. Production capacity of approximately 12 million packs per year with batch sizes between 30L and 1,000L. For pharmaceutical, medical device, and food supplement manufacturers requiring EU-GMP compliant sterile production.
• Non-Sterile Solutions (Unsterile Lösungen) Production of non-sterile liquid pharmaceuticals, medical devices, and food supplements with expertise in preservation options and filling of various container systems. For manufacturers requiring GMP-compliant non-sterile liquid production.
• Small Batch Service (Kleinchargenservice)

Quantifiable outcome

• Approximately 12 million packs per year production capacity in aseptic area
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Sigmapharm Arzneimittel GmbHcoreStrategic or Co-development Partner · 1 January 2000Sigmapharm Arzneimittel GmbH is the parent company from which MoNo was demerged in 2000. Both companies share the same Vienna and Hornstein locations and operate as a unified organization providing development, production, quality control, regulatory, and distribution services from a single source. Sigmapharm handles regulatory affairs, packaging design, warehousing, and dispatch logistics while MoNo focuses on manufacturing. Medical device information is distributed through Sigmapharm's website. The partnership dates back to 1949 when Sigmapharm was founded.

Scale indicators3 records

Recent moves7 records

Expansion highlights3 records

Others

• SCHOTT AG: Leading manufacturer of pharmaceutical glass packaging — vials, ampoules, and syringes — that supplies primary packaging used by sterile injectable and ophthalmic CDMOs including MoNo. Comparable as a critical supplier/ecosystem participant in the aseptic liquid manufacturing value chain.
• Gerresheimer AG: Global manufacturer of pharmaceutical glass and plastic packaging, including vials, dropper bottles, and ophthalmic containers. Comparable to MoNo's operations as a primary container supplier for ENT and eye-drop products manufactured at MoNo's facilities.

Broad incumbents

• CordenPharma: European CDMO providing sterile injectable and ophthalmic manufacturing, as well as APIs and peptides. Comparable to MoNo in delivering aseptic liquid fill-finish to pharma clients, though with a wider range of integrated capabilities.
• Catalent Pharma Solutions: Global CDMO with extensive aseptic fill-finish, softgel, and biologics capabilities. Comparable to MoNo in sterile liquid contract manufacturing and small-batch clinical-to-commercial services, but at meaningfully greater scale and geographic breadth.
• Recipharm AB: Swedish-headquartered European CDMO offering sterile injectables, ophthalmics, and inhalation manufacturing. Comparable to MoNo in providing GMP-certified sterile liquid manufacturing to pharma clients, though with a much broader service portfolio and site footprint.
• Fareva: French-headquartered pharmaceutical CDMO with sterile and non-sterile manufacturing, including liquid and semi-solid forms. Comparable to MoNo in offering GMP-certified aseptic fill-finish as part of a broader contract manufacturing portfolio.

Direct peers

• PCI Pharma Services: Global CDMO with strong sterile fill-finish, clinical trial supply, and packaging/serialization services. Comparable to MoNo in combining aseptic manufacturing, clinical trial medication, and FMD-compliant serialization into a single service offering.
• Aenova Group: A leading European pharmaceutical CDMO with sterile and non-sterile manufacturing, oral solids, and aseptic fill-finish capabilities. Comparable to MoNo as a B2B contract manufacturer serving small-to-mid pharma across multiple dosage forms, including sterile liquids.
• Haupt Pharma: European CDMO (Aenova subsidiary) focused on sterile and non-sterile pharmaceutical manufacturing including injectables and ophthalmics. Directly comparable to MoNo's sterile/non-sterile liquid manufacturing niche and small-to-mid batch positioning.
• NextPharma: European CDMO specializing in aseptic and non-sterile manufacturing, including ophthalmics and ENT liquids. Closely comparable to MoNo's core offering of small-to-mid batch sterile liquid manufacturing, particularly for niche and rare-disease pharma clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mono-chem-pharm

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MoNo chem-pharm Produkte